24 February 2017
Summary of fees and charges arising from the Australian Narcotic Drugs legislation and associated regulations
7 February 2017
This guidance is for stakeholders who are applying for a new licence under the Narcotic Drugs Act 1967 to cultivate, produce and/or manufacture cannabis or cannabis material for the purposes of patient supply or research using downloadable flat forms
Information on how ODC implements cost recovery for regulatory activities
13 December 2016
Information on how ODC implements cost recovery for regulatory activities
Guidance for completing import/export licence applications for narcotic, psychotropic and precursor substances
8 December 2016
Guidance for completing import/export licence applications for narcotic, psychotropic and precursor substances
8 December 2016
Guidance for completing import permit applications for narcotic and psychotropic substances
Guidance for completing import permit applications for precursor substances
8 December 2016
Guidance for completing import permit applications for precursor substances
Guidance for completing: Application for a licence to import - Special Access Scheme (SAS) only; Application for a permit to import drug substances - Special Access Scheme (SAS) only
8 December 2016
Guidance for completing: Application for a licence to import - Special Access Scheme (SAS) only; Application for a permit to import drug substances - Special Access Scheme (SAS) only
Guidance for completing applications for a permit to import antibiotics
8 December 2016
Guidance for completing applications for a permit to import antibiotics
Guidance for completing an application for permission to import substances under Regulation 5G and 5H of the Customs (Prohibited Imports) Regulations 1956
8 December 2016
Guidance for completing an application for permission to import substances under Regulation 5G and 5H of the Customs (Prohibited Imports) Regulations 1956
Guidance for completing applications for a permit to import kava for medical and/or scientific purposes
8 December 2016
Guidance for completing applications for a permit to import kava for medical and/or scientific purposes
Pre-export notification for a precursor substance: Substances listed in Schedule 9 of the Customs (Prohibited Exports) Regulations 1958
8 December 2016
Pre-export notification for a precursor substance: Substances listed in Schedule 9 of the Customs (Prohibited Exports) Regulations 1958
Guidance for completing the Notification of antibiotic imports (previously Antibiotic - Form F)
8 December 2016
Guidance for completing the Notification of antibiotic imports (previously Antibiotic - Form F)
Guidance for completing export permit applications for narcotic, psychotropic and precursor substances
7 December 2016
Guidance for completing export permit applications for narcotic, psychotropic and precursor substances
2 November 2016
Further information on medicinal cannabis manufacture licences and permit applications
30 October 2016
This guideline is for manufacture licences only
24 October 2016
The Office of Drug Control is the regulatory body responsible for licensing cultivation and production of cannabis for medicinal purposes
21 October 2016
Guideline to assist licence applicants and holders in designing and meeting security standards that are required for the cultivation, production and manufacture of medicinal cannabis
21 October 2016
Guideline to assist licence applicants and holders to assess whether they are fit and proper to hold a licence to cultivate, produce or manufacture under the Narcotic Drugs Act 1967
21 October 2016
Guideline to assist licence applicants and holders in designing and meeting standards required for record keeping and reporting matters related to cultivation, production and manufacture of medicinal cannabis
Deloitte Access Economics
12 October 2016
Medicinal cannabis cost modeling information is now available